Supriya Lifescience Limited (BOM:543434)
India · Delayed Price · Currency is INR 903.85
-14.90 (-1.62%)
At close: Sep 11, 2026
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 72.58 billion as of September 11, 2026. Its market cap has increased by 37.77% in one year.
Market Cap
72.58B
Enterprise Value
71.84B
Revenue
8.73B
Ranking
n/a
PE Ratio
36.59
Stock Price
903.85
ChartMarket Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 72.58B, an increase of 130.72%. That is a compound annual growth rate of 19.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 72.58B | 19.99% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 162.36B |
| Viyash Scientific | 112.28B |
| Procter & Gamble Health | 89.81B |
| Bliss GVS Pharma | 76.78B |
| Sanofi India | 70.93B |
| Morepen Laboratories | 63.54B |
| Novartis India | 59.09B |
| FDC Limited | 55.49B |